|
?:authorAffiliation
|
-
[\'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA; PhD Program in Virology, Division of Medical Sciences, Harvard University, Boston, MA, USA.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA; PhD Program in Immunology and Virology, University of Duisburg-Essen, Essen, Germany.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.\', \'Department of Medicine, University of Washington, Seattle, WA, USA.\', \'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.\', \'SeromYx Systems, Cambridge, MA, USA.\', \'Division of Molecular Medicine, Boston Children\'s Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.\', \'Infectious Disease Division, Massachusetts General Hospital, Boston, MA, USA.\', \'Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: helenchu@uw.edu.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA. Electronic address: galter@partners.org.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}